Loading clinical trials...
Loading clinical trials...
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis
Conditions
Interventions
TRC101
Placebo
Locations
44
United States
Investigative Site 55
Phoenix, Arizona, United States
Investigative Site 56
Chula Vista, California, United States
Investigative Site 91
Los Angeles, California, United States
Investigative Site 59
Hialeah, Florida, United States
Investigative Site 54
Hollywood, Florida, United States
Investigative Site 93
Hollywood, Florida, United States
Start Date
September 26, 2017
Primary Completion Date
May 4, 2018
Completion Date
May 15, 2018
Last Updated
April 26, 2021
NCT06366230
NCT05113641
NCT04727528
NCT05285189
NCT03846258
NCT04229069
Lead Sponsor
Tricida, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions